Story thread · 4 reports / 2 sources
MapLight Therapeutics stock tumbles 50% on mixed phase 2 schizophrenia data
seekingalpha.com · 15d
First report: Robin Energy prices $3M public offering of common stock — seekingalpha.com, 18d
The coverage
- MapLight Therapeutics stock tumbles 40% on trial results
investing.com · 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.